Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
97.74
+2.02 (2.12%)
At close: Apr 28, 2026, 4:00 PM EDT
97.70
-0.04 (-0.04%)
After-hours: Apr 28, 2026, 6:04 PM EDT
Incyte Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for Incyte stock have an average target of 104.05, with a low estimate of 60 and a high estimate of 135. The average target predicts an increase of 6.46% from the current stock price of 97.74.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Incyte stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 6 | 6 | 6 |
| Buy | 5 | 6 | 5 | 5 | 5 | 5 |
| Hold | 10 | 10 | 10 | 9 | 9 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 21 | 21 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +38.12% | Apr 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +38.12% | Mar 30, 2026 |
| UBS | UBS | Hold Maintains $104 → $94 | Hold | Maintains | $104 → $94 | -3.83% | Mar 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +38.12% | Mar 25, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $120 → $94 | Strong Buy → Hold | Downgrades | $120 → $94 | -3.83% | Mar 16, 2026 |
Financial Forecast
Revenue This Year
5.68B
from 5.14B
Increased by 10.44%
Revenue Next Year
6.30B
from 5.68B
Increased by 10.99%
EPS This Year
7.74
from 6.41
Increased by 20.75%
EPS Next Year
9.14
from 7.74
Increased by 18.04%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 6.1B | 7.8B | ||||||
| Avg | 5.7B | 6.3B | ||||||
| Low | 5.3B | 5.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 18.1% | 37.8% | ||||||
| Avg | 10.4% | 11.0% | ||||||
| Low | 3.8% | -0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 8.85 | 11.57 | ||||||
| Avg | 7.74 | 9.14 | ||||||
| Low | 6.73 | 7.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 38.1% | 49.5% | ||||||
| Avg | 20.8% | 18.0% | ||||||
| Low | 5.0% | 0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.